Matches in Wikidata for { <http://www.wikidata.org/entity/Q37737797> ?p ?o ?g. }
- Q37737797 description "article científic" @default.
- Q37737797 description "article scientifique" @default.
- Q37737797 description "articolo scientifico" @default.
- Q37737797 description "artigo científico" @default.
- Q37737797 description "artículu científicu espublizáu en 2017" @default.
- Q37737797 description "bilimsel makale" @default.
- Q37737797 description "scientific article published on 17 March 2017" @default.
- Q37737797 description "vedecký článok" @default.
- Q37737797 description "vetenskaplig artikel" @default.
- Q37737797 description "videnskabelig artikel" @default.
- Q37737797 description "vědecký článek" @default.
- Q37737797 description "wetenschappelijk artikel" @default.
- Q37737797 description "wissenschaftlicher Artikel" @default.
- Q37737797 description "наукова стаття, опублікована в березні 2017" @default.
- Q37737797 description "научни чланак" @default.
- Q37737797 description "գիտական հոդված հրատարակված 2017 թվականի մարտի 17-ին" @default.
- Q37737797 description "مقالة علمية نشرت في 17 مارس 2017" @default.
- Q37737797 name "Prospective longitudinal study on quality of life in relapsed/refractory multiple myeloma patients receiving second- or third-line lenalidomide or bortezomib treatment" @default.
- Q37737797 name "Prospective longitudinal study on quality of life in relapsed/refractory multiple myeloma patients receiving second- or third-line lenalidomide or bortezomib treatment" @default.
- Q37737797 name "Prospective longitudinal study on quality of life in relapsed/refractory multiple myeloma patients receiving second- or third-line lenalidomide or bortezomib treatment" @default.
- Q37737797 type Item @default.
- Q37737797 label "Prospective longitudinal study on quality of life in relapsed/refractory multiple myeloma patients receiving second- or third-line lenalidomide or bortezomib treatment" @default.
- Q37737797 label "Prospective longitudinal study on quality of life in relapsed/refractory multiple myeloma patients receiving second- or third-line lenalidomide or bortezomib treatment" @default.
- Q37737797 label "Prospective longitudinal study on quality of life in relapsed/refractory multiple myeloma patients receiving second- or third-line lenalidomide or bortezomib treatment" @default.
- Q37737797 prefLabel "Prospective longitudinal study on quality of life in relapsed/refractory multiple myeloma patients receiving second- or third-line lenalidomide or bortezomib treatment" @default.
- Q37737797 prefLabel "Prospective longitudinal study on quality of life in relapsed/refractory multiple myeloma patients receiving second- or third-line lenalidomide or bortezomib treatment" @default.
- Q37737797 prefLabel "Prospective longitudinal study on quality of life in relapsed/refractory multiple myeloma patients receiving second- or third-line lenalidomide or bortezomib treatment" @default.
- Q37737797 P1433 Q37737797-B4C9333F-6BB2-4EBE-84B0-B362E48BE1B1 @default.
- Q37737797 P1476 Q37737797-431948A5-8626-47C3-B7CA-ECBAE97B614D @default.
- Q37737797 P2093 Q37737797-018B296A-158A-48D2-A8CE-88D5C63A9405 @default.
- Q37737797 P2093 Q37737797-146DB5C6-8F13-4934-A085-27B37349A6FC @default.
- Q37737797 P2093 Q37737797-1D40719F-B536-4C7C-A799-DF98CBF963B2 @default.
- Q37737797 P2093 Q37737797-2D571121-DBBE-4EC8-ACCD-7054EBCE280F @default.
- Q37737797 P2093 Q37737797-40768501-C1DB-482E-B6A1-569C91D38841 @default.
- Q37737797 P2093 Q37737797-4FB7EE81-AFAE-4782-9203-83C14863D84C @default.
- Q37737797 P2093 Q37737797-56F1891E-AF2B-4C48-BF68-49550CF0516A @default.
- Q37737797 P2093 Q37737797-D6CC263F-0A10-4320-92A7-F1701A2B0E12 @default.
- Q37737797 P2093 Q37737797-E1BE6E3A-5427-48A5-AB63-88484999719F @default.
- Q37737797 P275 Q37737797-1f213ab6-0ea4-483d-bdd8-c7c6b4c5eb3e @default.
- Q37737797 P2860 Q37737797-007AE39D-033C-4D26-8F4B-23A5EEF3CFEF @default.
- Q37737797 P2860 Q37737797-1B4A8EB6-14F3-4B4D-8DAB-61ECAAEE2123 @default.
- Q37737797 P2860 Q37737797-220452DF-2248-49F0-B55E-C536A58BDC18 @default.
- Q37737797 P2860 Q37737797-2844D932-1191-465A-8397-BE9027DB3736 @default.
- Q37737797 P2860 Q37737797-2ACE55A6-2DC7-4036-9DDA-65612CDE137A @default.
- Q37737797 P2860 Q37737797-31448B97-2E1A-43F8-A616-1A51B247A6EE @default.
- Q37737797 P2860 Q37737797-375B105D-6BED-4324-B20B-61C543868E3B @default.
- Q37737797 P2860 Q37737797-3CF554C1-50E4-4B7A-9C39-D911167D49C3 @default.
- Q37737797 P2860 Q37737797-419610B9-3904-4B31-ACA1-99ECFDE9CE8F @default.
- Q37737797 P2860 Q37737797-42BC8FBE-4E2E-455A-9FF5-9CDE4644C029 @default.
- Q37737797 P2860 Q37737797-44CAEFD9-57F2-47BC-9836-359E3B8357DA @default.
- Q37737797 P2860 Q37737797-452819AE-75F7-4E7B-916C-1CED07FB7AA0 @default.
- Q37737797 P2860 Q37737797-4C6E02C8-7E59-42BA-BDEC-919808140E3F @default.
- Q37737797 P2860 Q37737797-4D9F9ADE-3671-46BA-B589-E9F786B0D0D9 @default.
- Q37737797 P2860 Q37737797-6C1DA67E-4EF1-413C-9729-F1DEC1B78292 @default.
- Q37737797 P2860 Q37737797-8B423D16-B3D9-48B2-9DB8-BD64B20C0FF8 @default.
- Q37737797 P2860 Q37737797-8E556825-07F9-44D5-8EEC-44C14575C341 @default.
- Q37737797 P2860 Q37737797-9B58AAFE-83E4-41C7-B2E0-51F3B95EB284 @default.
- Q37737797 P2860 Q37737797-9F738A7B-A328-478F-8E91-09E90751C400 @default.
- Q37737797 P2860 Q37737797-A8417AF8-E0CB-4DD3-B2AD-1ED177CE9E78 @default.
- Q37737797 P2860 Q37737797-ACA72D7A-6EC6-48DE-85DD-469F35B4C7C8 @default.
- Q37737797 P2860 Q37737797-ADBD53B2-5DBA-475A-9BFF-83D114D6A49E @default.
- Q37737797 P2860 Q37737797-C0BA7C6A-E655-40E4-B5C7-00AAF4DD833B @default.
- Q37737797 P2860 Q37737797-CAC72E93-405B-4072-85A0-D9C4690888CD @default.
- Q37737797 P2860 Q37737797-CB22742C-9A9A-45BF-8EC0-F5541417CF1E @default.
- Q37737797 P2860 Q37737797-E214EBCF-E6C4-4BCC-BE89-80049F9C7DE6 @default.
- Q37737797 P2860 Q37737797-EBE44801-D2EB-41CD-BB93-27F72DBAC06C @default.
- Q37737797 P2860 Q37737797-EF5D313A-FCB8-40F7-B4D3-E88B85E0923D @default.
- Q37737797 P2860 Q37737797-FC97141F-6AB7-40AC-837E-A39F64B3C5A9 @default.
- Q37737797 P2888 Q37737797-A2A4670E-7CEE-42EC-BF62-20CCDE583052 @default.
- Q37737797 P304 Q37737797-E646AB59-536B-4903-A833-DAA605DAFF39 @default.
- Q37737797 P31 Q37737797-DDA70196-7E0B-4E17-BB25-A0D6EBDD9ABC @default.
- Q37737797 P356 Q37737797-33EBEB05-7C2C-4EB5-94B3-4F1A5B5FE5AC @default.
- Q37737797 P433 Q37737797-25CEFC25-6247-40E1-96C6-565FAB728CF6 @default.
- Q37737797 P478 Q37737797-CDC917E0-9252-4EAF-878A-8B8EBC54A174 @default.
- Q37737797 P577 Q37737797-AC36807B-A713-4ECC-A368-82486D42B0C2 @default.
- Q37737797 P6216 Q37737797-9caa6067-bd48-4553-a599-c685478ca756 @default.
- Q37737797 P698 Q37737797-7EDFED6A-9D31-4FBF-9D1B-58B86BDEC88D @default.
- Q37737797 P921 Q37737797-89A4B97A-6CBE-4BDC-8615-C7155CDDD88D @default.
- Q37737797 P921 Q37737797-D39B769E-E694-4090-9D6E-422CAD55F019 @default.
- Q37737797 P932 Q37737797-2FD22D20-2D78-46D3-8268-4663E3779FA5 @default.
- Q37737797 P356 BCJ.2017.20 @default.
- Q37737797 P698 28304402 @default.
- Q37737797 P1433 Q2464036 @default.
- Q37737797 P1476 "Prospective longitudinal study on quality of life in relapsed/refractory multiple myeloma patients receiving second- or third-line lenalidomide or bortezomib treatment" @default.
- Q37737797 P2093 "B Arnould" @default.
- Q37737797 P2093 "C Kyriakou" @default.
- Q37737797 P2093 "H Gilet" @default.
- Q37737797 P2093 "I Vande Broek" @default.
- Q37737797 P2093 "M T Petrucci" @default.
- Q37737797 P2093 "P Bacon" @default.
- Q37737797 P2093 "P Lewis" @default.
- Q37737797 P2093 "P Murphy" @default.
- Q37737797 P2093 "X Leleu" @default.
- Q37737797 P275 Q20007257 @default.
- Q37737797 P2860 Q28080999 @default.
- Q37737797 P2860 Q29615569 @default.
- Q37737797 P2860 Q29615701 @default.
- Q37737797 P2860 Q30650394 @default.
- Q37737797 P2860 Q33377526 @default.
- Q37737797 P2860 Q33409172 @default.